In vitro and in vivo CAFs-secreted exosomal SNHG3 knockdown strategies demonstrated a reversal of the metabolic reprogramming, leading to a decreased breast cancer cell glycolysis and growth [25]. Here, SNHG3 is linked to breast carcinoma.